Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
InMed Pharmaceuticals Inc. | Sr VP & General Manager | Employee Stock Option (Right to Buy) | 48K | Dec 23, 2023 | Direct | ||
InMed Pharmaceuticals Inc. | Sr VP & General Manager | Employee Stock Option (Right to Buy) | 3.9K | Dec 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INM | InMed Pharmaceuticals Inc. | Dec 20, 2024 | 1 | $0 | 4 | Dec 23, 2024 | Sr VP & General Manager |
INM | InMed Pharmaceuticals Inc. | Dec 23, 2023 | 1 | $0 | 4 | Dec 26, 2023 | Sr VP & General Manager |
INM | InMed Pharmaceuticals Inc. | Dec 16, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Sr VP & General Manager |
INM | InMed Pharmaceuticals Inc. | Nov 14, 2022 | 1 | $0 | 4/A | Nov 18, 2022 | Sr VP & General Manager |
INM | InMed Pharmaceuticals Inc. | Jan 6, 2022 | 1 | $10.7K | 4 | Jan 6, 2022 | SVP, GM of BayMedica LLC |
INM | InMed Pharmaceuticals Inc. | Dec 30, 2021 | 1 | $10.7K | 4 | Dec 30, 2021 | SVP, GM of BayMedica LLC |
INM | InMed Pharmaceuticals Inc. | Nov 15, 2021 | 1 | $6.85K | 4 | Nov 15, 2021 | SVP, GM of BayMedica LLC |
INM | InMed Pharmaceuticals Inc. | Nov 2, 2021 | 0 | $0 | 3 | Nov 9, 2021 | SVP & GM of BayMedica LLC |